On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against cancer-causing HPV in China, which previously powered Merck’s growth.

Ninety-nine percent of cervical cancers are caused by HPV. What is the Cervarix HPV vaccine? The Cervarix HPV vaccine protects against the two strains of HPV (16 and 18) that cause cervical cancer ...

There are currently three types of HPV vaccines available: Gardasil 9, Gardasil, and Cervarix. Gardasil 9 protects against nine of the most common HPV strains, offering up to 90% protection ...

Gardasil is approved by the FDA for girls and women ages 9 to 26. The CDC and the American ... There's a second vaccine in the works: Cervarix, from GlaxoSmithKline. Cervarix targets two HPV ...

The first vaccine used was GlaxoSmithKline's Cervarix, which was replaced by MSD's Gardasil in 2012. The research by King's College London is the first direct evidence that HPV vaccination makes a ...

have both been awarded a significant portion of the UNICEF HPV vaccine tender in order to provide the vaccinations. GSK is to provide a supply of Cervarix® (Human Papillomavirus vaccine [Types 16 ...

Gardasil has also been licensed in over 40 countries worldwide. Cervarix is awaiting European ... Expert Rev. Mol. Med. 6(9), 1-21 (2004).